+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Multiplex Detection Immunoassays Market by Technique, Assay Type, Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888894
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Multiplex Detection Immunoassays Market size was estimated at USD 2.11 billion in 2023, USD 2.25 billion in 2024, and is expected to grow at a CAGR of 6.92% to reach USD 3.37 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multiplex Detection Immunoassays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multiplex Detection Immunoassays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Detection Immunoassays Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Advanced Cell Diagnostics, Inc., Aehealth Limited, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories, Elabscience Biotechnology Inc., Fortis Life Sciences LLC, Illumina Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Meso Scale Diagnostics, LLC, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Quansys Biosciences Inc., Quanterix Corporation, R&D Systems, Inc., Randox Laboratories Ltd., Sartorius AG, Scienion by Bico Company, Scorpius BioManufacturing, Seegene Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Multiplex Detection Immunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technique
    • Biosensor-Based Techniques
    • Nucleic Acid-Based Techniques
    • Protein-Based Techniques
  • Assay Type
    • Antibody Arrays
    • Bead-based assay
    • Blends Protein Arrays (Multiplexed ELISA)
    • Magnetic Bead-based
    • Non-magnetic Bead-based
    • Planar Assay
  • Application
    • Disease Testing
    • Food Contamination Testing
    • Research and Development
    • Veterinary Disease Testing
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Clinical Research Organizations
    • Diagnostic Centers
    • Food & Beverages Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Multiplex Detection Immunoassays Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multiplex Detection Immunoassays Market?
  3. What are the technology trends and regulatory frameworks in the Multiplex Detection Immunoassays Market?
  4. What is the market share of the leading vendors in the Multiplex Detection Immunoassays Market?
  5. Which modes and strategic moves are suitable for entering the Multiplex Detection Immunoassays Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Multiplex Detection Immunoassays Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of chronic and infectious diseases across the globe
5.1.1.2. Growing preference for personalized -precision medicines
5.1.1.3. Favorable government funding for drug development and research activities
5.1.2. Restraints
5.1.2.1. Associated complexity and high cost of equipment
5.1.3. Opportunities
5.1.3.1. Emergence of advanced technologies in the healthcare and pharmaceutical industry
5.1.3.2. Rapid development of automated instruments in clinical diagnostics
5.1.4. Challenges
5.1.4.1. Dearth of skilled and experienced subject matter experts
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Multiplex Detection Immunoassays Market, by Technique
6.1. Introduction
6.2. Biosensor-Based Techniques
6.3. Nucleic Acid-Based Techniques
6.4. Protein-Based Techniques
7. Multiplex Detection Immunoassays Market, by Assay Type
7.1. Introduction
7.2. Antibody Arrays
7.3. Bead-based assay
7.4. Blends Protein Arrays (Multiplexed ELISA)
7.5. Magnetic Bead-based
7.6. Non-magnetic Bead-based
7.7. Planar Assay
8. Multiplex Detection Immunoassays Market, by Application
8.1. Introduction
8.2. Disease Testing
8.3. Food Contamination Testing
8.4. Research and Development
8.5. Veterinary Disease Testing
9. Multiplex Detection Immunoassays Market, by End-User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Biotechnology Companies
9.4. Clinical Research Organizations
9.5. Diagnostic Centers
9.6. Food & Beverages Companies
9.7. Pharmaceutical Companies
10. Americas Multiplex Detection Immunoassays Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Multiplex Detection Immunoassays Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Multiplex Detection Immunoassays Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abcam PLC
14.1.2. Advanced Cell Diagnostics, Inc.
14.1.3. Aehealth Limited
14.1.4. Assay Genie
14.1.5. Becton, Dickinson and Company
14.1.6. Bio-Rad Laboratories, Inc.
14.1.7. Charles River Laboratories
14.1.8. Elabscience Biotechnology Inc.
14.1.9. Fortis Life Sciences LLC
14.1.10. Illumina Inc.
14.1.11. Luminex Corporation by DiaSorin S.p.A.
14.1.12. Merck KGaA
14.1.13. Meso Scale Diagnostics, LLC
14.1.14. PerkinElmer Inc.
14.1.15. Promega Corporation
14.1.16. Qiagen N.V.
14.1.17. Quansys Biosciences Inc.
14.1.18. Quanterix Corporation
14.1.19. R&D Systems, Inc.
14.1.20. Randox Laboratories Ltd.
14.1.21. Sartorius AG
14.1.22. Scienion by Bico Company
14.1.23. Scorpius BioManufacturing
14.1.24. Seegene Inc.
14.1.25. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET RESEARCH PROCESS
FIGURE 2. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET DYNAMICS
FIGURE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
FIGURE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
FIGURE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOSENSOR-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PROTEIN-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ANTIBODY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BEAD-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BLENDS PROTEIN ARRAYS (MULTIPLEXED ELISA), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NON-MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PLANAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD CONTAMINATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY VETERINARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD & BEVERAGES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 42. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 64. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 68. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 77. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 101. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 137. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 150. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 153. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 154. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 157. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 158. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 186. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 197. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 198. MULTIPLEX DETECTION IMMUNOASSAYS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abcam PLC
  • Advanced Cell Diagnostics, Inc.
  • Aehealth Limited
  • Assay Genie
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories
  • Elabscience Biotechnology Inc.
  • Fortis Life Sciences LLC
  • Illumina Inc.
  • Luminex Corporation by DiaSorin S.p.A.
  • Merck KGaA
  • Meso Scale Diagnostics, LLC
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quansys Biosciences Inc.
  • Quanterix Corporation
  • R&D Systems, Inc.
  • Randox Laboratories Ltd.
  • Sartorius AG
  • Scienion by Bico Company
  • Scorpius BioManufacturing
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.37 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal

Related Topics

Related Reports

Multiplex Detection Immunoassays - Global Strategic Business Report - Product Image

Multiplex Detection Immunoassays - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Multiplex Detection Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Multiplex Detection Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 228 Pages
  • Global
Multiplex Detection Immunoassay Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Multiplex Detection Immunoassay Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
Lateral Flow Immunoassay (LFIA)-based Rapid Test Global Market Report 2024 - Product Image

Lateral Flow Immunoassay (LFIA)-based Rapid Test Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030 - Product Image

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From

About the Multiplex Detection Immunoassays Market

Within the field of In Vitro Diagnostics (IVD), multiplex detection immunoassays represent a technological advancement enabling the simultaneous detection and quantification of multiple analytes, such as proteins, pathogens, or biomarkers, from a single sample. This approach contrasts with traditional methods that require separate tests for each analyte. The increased efficiency and comprehensive data generated by multiplex immunoassays facilitate a more robust understanding of patient samples, aiding in disease diagnosis, monitoring, and management. The use of multiplex detection immunoassays spans various applications, including infectious disease testing, autoimmune disease diagnostics, allergy testing, oncology, and pharmacogenomics, among others. These tests employ various platforms like planar arrays or bead-based systems, with detection methods that include fluorescent, electrochemiluminescent, or colorimetric readouts. The ability of multiplex immunoassays to provide quick and reliable results is valued in both clinical and research settings, leading to their integration into laboratories and hospitals. Some companies that operate in the multiplex detection immunoassays market are Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthineers, Luminex Corporation, and F. Hoffmann-La Roche Ltd. These companies offer a range of products and services tailored to the needs of IVD, including multiplex assay kits, reagents, instruments, and software for data analysis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.